Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
KV Pharmaceutical Company - Key Facts
KV Pharmaceutical Company - Key Employees
KV Pharmaceutical Company - Key Employee Biographies
KV Pharmaceutical Company - Major Products and Services
KV Pharmaceutical Company - Pharmaceutical Pipeline Products Data
KV Pharmaceutical Company, Pipeline Products by Therapy Area
KV Pharmaceutical Company, Pipeline Products by Development Phase
KV Pharmaceutical Company - History
KV Pharmaceutical Company - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
KV Pharmaceutical Company - Business Description
KV Pharmaceutical Company - SWOT Analysis
SWOT Analysis - Overview
KV Pharmaceutical Company - Strengths
Strength - Strong In-house Research Activities
Strength - Proprietary Technological Platform
KV Pharmaceutical Company - Weaknesses
Weakness - High Indebtness
Weakness - History of Operating Losses
KV Pharmaceutical Company - Opportunities
Opportunity - Orphan Drug Designation for Makena
Opportunity - Emerging Markets
Opportunity - Changing Demographics
KV Pharmaceutical Company - Threats
Threat - Product Liability Claims
Threat - Tightening of FDAs Regulatory Oversight
Threat - Uncertain R&D Outcomes
Threat - Competitive Pressures
KV Pharmaceutical Company - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Companys Lifesciences Financial Deals and Alliances
KV Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
KV Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
KV Pharmaceutical Company, Recent Deals Summary
Section 5 – Companys Recent Developments
KV Pharmaceutical Company, Recent Developments
Aug 09, 2011: K-V Pharmaceutical Reports Total Revenue Of $6m In Q1 Fiscal 2012
Jun 10, 2011: K-V Pharmaceutical Reports Total Revenue Of $27.3m In Fiscal 2011
Mar 31, 2011: K-V Pharmaceutical Reports Total Revenue Of $5.42m In Q3 Fiscal 2011
Mar 22, 2011: K-V Pharmaceutical Reports Total Revenue Of $3.3m In Q2 Fiscal 2011
Mar 10, 2011: K-V Pharmaceutical Reports Total Revenue Of $3.38m In Q1 Fiscal 2011
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
KV Pharmaceutical Company, Key Facts
KV Pharmaceutical Company, Key Employees
KV Pharmaceutical Company, Key Employee Biographies
KV Pharmaceutical Company, Major Products and Services
KV Pharmaceutical Company, Number of Pipeline Products by Therapy Area
KV Pharmaceutical Company, Number of Pipeline Products by Development Stage
KV Pharmaceutical Company, Pipeline Products By Therapy Area and Development Phase
KV Pharmaceutical Company, History
KV Pharmaceutical Company, Subsidiaries
KV Pharmaceutical Company, Key Competitors
KV Pharmaceutical Company, Ratios based on current share price
KV Pharmaceutical Company, Annual Ratios
KV Pharmaceutical Company, Interim Ratios
KV Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
KV Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
KV Pharmaceutical Company, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
KV Pharmaceutical Company, Pipeline Products by Therapy Area
KV Pharmaceutical Company, Pipeline Products by Development Phase
KV Pharmaceutical Company, Performance Chart (2007 - 2011)
KV Pharmaceutical Company, Ratio Charts
KV Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
KV Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012 27